Protective effect of Salvianolic acid B against atherosclerosis: a preclinical systematic review and meta-analysis
Our findings suggest that Sal B effectively delays the progression of atherosclerosis and represents a promising anti-atherosclerotic drug candidate. Further studies are required to translate these promising preclinical findings into the clinical treatment of atherosclerosis.
Authors
- Aimei Lu
- Huanlin Wu (ORCID: https://orcid.org/0000-0001-8949-4446)
- Xing Ji
- Xiaomeng Hu (ORCID: https://orcid.org/0000-0003-1839-6739)
- Kai‐Lin Huang (ORCID: https://orcid.org/0000-0001-9031-5863)
Institutions
- Beijing University of Chinese Medicine (CN)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-06-18
- DOI
- https://doi.org/10.3389/fphar.2025.1548811
- Citations
- 1
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.80